These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
[x]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the quarterly period ended May 1, 2011
|
[_]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
94-3177549
|
(State or Other Jurisdiction of
|
(I.R.S. Employer
|
Incorporation or Organization)
|
Identification No.)
|
Large accelerated filer
x
|
Accelerated filer
o
|
Non-accelerated filer
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
o
|
Page
|
|||||
|
|||||
|
|
||||
|
3
|
||||
|
4
|
||||
|
5
|
||||
|
6
|
||||
|
|
24
|
|||
|
|
33
|
|||
|
|
33
|
|||
|
|||||
|
|
34
|
|||
|
|
34
|
|||
|
|
49
|
|||
50
|
|||||
|
51
|
Three Months Ended
|
||||||||
May 1,
2011
|
May 2,
2010
|
|||||||
Revenue
|
$
|
962,039
|
$
|
1,001,813
|
||||
Cost of revenue
|
477,536
|
545,436
|
||||||
Gross profit
|
484,503
|
456,377
|
||||||
Operating expenses
|
||||||||
Research and development
|
231,524
|
218,105
|
||||||
Sales, general and administrative
|
98,117
|
90,879
|
||||||
Total operating expenses
|
329,641
|
308,984
|
||||||
Income from operations
|
154,862
|
147,393
|
||||||
Interest income
|
5,313
|
5,571
|
||||||
Other income (expense), net
|
(3,690
|
)
|
(2,239
|
)
|
||||
Income before income tax expense
|
156,485
|
150,725
|
||||||
Income tax expense
|
21,266
|
13,131
|
||||||
Net income
|
$
|
135,219
|
$
|
137,594
|
||||
Basic net income per share
|
$
|
0.23
|
$
|
0.24
|
||||
Shares used in basic per share computation
|
594,802
|
567,183
|
||||||
Diluted net income per share
|
$
|
0.22
|
$
|
0.23
|
||||
Shares used in diluted per share computation
|
613,474
|
590,997
|
May 1,
2011
|
January 30,
2011
|
|||||||
ASSETS
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
683,633
|
$
|
665,361
|
||||
Marketable securities
|
2,042,908
|
1,825,202
|
||||||
Accounts receivable, net
|
343,202
|
348,770
|
||||||
Inventories
|
380,964
|
345,525
|
||||||
Prepaid expenses and other
|
36,600
|
32,636
|
||||||
Deferred income taxes
|
9,456
|
9,456
|
||||||
Total current assets
|
3,496,763
|
3,226,950
|
||||||
Property and equipment, net
|
553,366
|
568,857
|
||||||
Goodwill
|
369,844
|
369,844
|
||||||
Intangible assets, net
|
278,761
|
288,745
|
||||||
Deposits and other assets
|
38,010
|
40,850
|
||||||
Total assets
|
$
|
4,736,744
|
$
|
4,495,246
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
Current liabilities:
|
||||||||
Accounts payable
|
$
|
346,295
|
$
|
286,138
|
||||
Accrued liabilities and other
|
634,871
|
656,544
|
||||||
Total current liabilities
|
981,166
|
942,682
|
||||||
Other long-term liabilities
|
284,813
|
347,713
|
||||||
Capital lease obligations, long-term
|
22,957
|
23,389
|
||||||
Commitments and contingencies - see Note 12
|
-
|
-
|
||||||
Stockholders’ equity:
|
||||||||
Preferred stock
|
-
|
-
|
||||||
Common stock
|
688
|
677
|
||||||
Additional paid-in capital
|
2,638,531
|
2,500,577
|
||||||
Treasury stock, at cost
|
(1,487,079
|
)
|
(1,479,392
|
)
|
||||
Accumulated other comprehensive income
|
11,121
|
10,272
|
||||||
Retained earnings
|
2,284,547
|
2,149,328
|
||||||
Total stockholders' equity
|
3,447,808
|
3,181,462
|
||||||
Total liabilities and stockholders' equity
|
$
|
4,736,744
|
$
|
4,495,246
|
Three Months Ended
|
|||||||
May 1,
2011
|
May 2,
2010
|
||||||
Cash flows from operating activities:
|
|||||||
Net income
|
$
|
135,219
|
$
|
137,594
|
|||
Adjustments to reconcile net income to net cash provided by operating activities:
|
|||||||
Depreciation and amortization
|
47,764
|
47,147
|
|||||
Stock-based compensation expense
|
31,739
|
25,177
|
|||||
Other
|
2,195
|
1,974
|
|||||
Deferred income taxes
|
8,415
|
14,398
|
|||||
Excess tax benefits from stock-based compensation
|
(13,644)
|
-
|
|||||
Changes in operating assets and liabilities:
|
|||||||
Accounts receivable
|
5,820
|
(155,011
|
)
|
||||
Inventories
|
(35,183
|
)
|
(56,816
|
)
|
|||
Prepaid expenses and other current assets
|
(3,964
|
)
|
2,685
|
||||
Deposits and other assets
|
3,226
|
1,061
|
|||||
Accounts payable
|
53,740
|
16,822
|
|||||
Accrued liabilities and other long-term liabilities
|
(63,127
|
)
|
(40,428
|
)
|
|||
Net cash provided by (used in) operating activities
|
172,200
|
(5,397
|
)
|
||||
Cash flows from investing activities:
|
|||||||
Purchases of marketable securities
|
(427,874
|
)
|
(226,963
|
)
|
|||
Proceeds from sales and maturities of marketable securities
|
206,946
|
186,701
|
|||||
Purchases of property and equipment and intangible assets
|
(31,195
|
)
|
(17,080
|
)
|
|||
Other
|
(383
|
)
|
-
|
||||
Net cash used in investing activities
|
(252,506
|
)
|
(57,342
|
)
|
|||
Cash flows from financing activities:
|
|||||||
Proceeds from issuance of common stock under employee stock plans
|
85,286
|
63,062
|
|||||
Payments under capital lease obligations
|
(352
|
)
|
(282
|
)
|
|||
Excess tax benefits from stock-based compensation
|
13,644
|
-
|
|||||
Net cash provided by financing activities
|
98,578
|
62,780
|
|||||
Change in cash and cash equivalents
|
18,272
|
41
|
|||||
Cash and cash equivalents at beginning of period
|
665,361
|
447,221
|
|||||
Cash and cash equivalents at end of period
|
$
|
683,633
|
$
|
447,262
|
|||
Supplemental disclosures of cash flow information:
|
|||||||
Cash paid for income taxes, net
|
$
|
1,404
|
$
|
1,089
|
|||
Cash paid for interest on capital lease obligations
|
$
|
761
|
$
|
795
|
|||
Other non-cash activities:
|
|||||||
Assets acquired by assuming related liabilities
|
6,416
|
1,568
|
|||||
Change in unrealized gains from marketable securities
|
$
|
850
|
$
|
(1,298
|
)
|
Three Months Ended
|
||||||||
May 1,
2011
|
May 2,
2010
|
|||||||
Cost of revenue
|
$
|
2,477
|
$
|
1,803
|
||||
Research and development
|
18,589
|
14,614
|
||||||
Sales, general and administrative
|
10,673
|
8,760
|
||||||
Total
|
$
|
31,739
|
$
|
25,177
|
Three Months Ended
|
|||||||
May 1,
2011
|
May 2,
2010
|
||||||
Stock Options
|
(Using a binomial model)
|
||||||
Expected life (in years)
|
4.4-5.4
|
3.8-5.7
|
|||||
Risk free interest rate
|
3.2%-3.8
|
%
|
2.7%-3.0
|
%
|
|||
Volatility
|
50%-61
|
%
|
43%-47
|
%
|
|||
Dividend yield
|
-
|
-
|
Three Months Ended
|
||||||
May 1,
2011
|
May 2,
2010
|
|||||
Employee Stock Purchase Plan
|
(Using a Black-Scholes model)
|
|||||
Expected life (in years)
|
0.5-2.0
|
0.5-2.0
|
||||
Risk free interest rate
|
0.2%-0.7
|
%
|
0.2%-0.8
|
%
|
||
Volatility
|
57
|
%
|
45
|
%
|
||
Dividend yield
|
-
|
-
|
Options Outstanding
|
Weighted Average Exercise Price
|
||||||
Stock Options
|
(In thousands)
|
(Per share)
|
|||||
Balances, January 30, 2011
|
44,001
|
$
|
12.88
|
||||
Granted
|
2,882
|
$
|
17.88
|
||||
Exercised
|
(6,926
|
)
|
$
|
10.01
|
|||
Cancelled
|
(456
|
)
|
$
|
17.63
|
|||
Balances, May 1, 2011
|
39,501
|
$
|
13.69
|
RSUs
Outstanding
|
Weighted Average Grant-Date Fair Value
|
||||||
Restricted Stock Units
|
(In thousands)
|
(Per share)
|
|||||
Balances, January 30, 2011
|
10,612
|
$
|
13.23
|
||||
Granted
|
3,280
|
$
|
18.18
|
||||
Vested
|
(1,299
|
)
|
$
|
12.50
|
|||
Cancelled
|
(234
|
)
|
$
|
14.03
|
|||
Balances, May 1, 2011
|
12,359
|
$
|
14.60
|
||||
(In thousands)
|
||||
Legal settlement
|
$
|
57,000
|
||
License to Intel
|
1,583,000
|
|||
License from Intel
|
(140,000
|
)
|
||
Total cash consideration
|
$
|
1,500,000
|
1.
|
Legal settlement
: In connection with the License Agreement, both parties agreed to settle all outstanding legal disputes. The fair value allocated to the settlement of $57.0 million was recorded in the fourth quarter of fiscal year 2011, as a benefit to operating expense.
|
2.
|
License to Intel:
We will recognize $1,583.0 million in total, or $66.0 million per quarter, as revenue over the term of the agreement of six years, the period over which Intel will have access to newly filed NVIDIA patents. Consideration received in advance of the performance period has been classified as deferred revenue. In the first quarter of fiscal year 2012, we recognized $22.0 million of revenue as our performance obligation under the agreement commencing on April 2011.
|
3.
|
License from Intel
: We recognized $140.0 million as an intangible asset upon execution of the agreement in the fourth quarter of fiscal year 2011. Amortization expense of $5.0 million per quarter will be charged to cost of sales over the seven year estimated useful life of the technology beginning in April 2011. In the first quarter of fiscal year 2012, we recognized amortization expense of $1.7 million.
|
Three Months Ended
|
||||||||
May 1, 2011
|
May 2, 2010
|
|||||||
(In thousands, except per share data)
|
||||||||
Numerator:
|
||||||||
Net income
|
$ | 135,219 | $ | 137,594 | ||||
Denominator:
|
||||||||
Denominator for basic net income per share, weighted average shares
|
594,802 | 567,183 | ||||||
Effect of dilutive securities:
|
||||||||
Equity awards outstanding
|
18,672 | 23,814 | ||||||
Denominator for diluted net income per share, weighted average shares
|
613,474 | 590,997 | ||||||
Net income per share:
|
||||||||
Basic net income per share
|
$ | 0.23 | $ | 0.24 | ||||
Diluted net income per share
|
$ | 0.22 | $ | 0.23 |
May 1, 2011
|
||||||||||||||||
Amortized
Cost
|
Unrealized
Gain
|
Unrealized
Loss
|
Estimated
Fair Value
|
|||||||||||||
(In thousands)
|
||||||||||||||||
Debt securities of United States government agencies
|
$ | 586,435 | $ | 1,074 | $ | (125 | ) | $ | 587,384 | |||||||
Corporate debt securities
|
954,909 | 3,585 | (43 | ) | 958,451 | |||||||||||
Mortgage backed securities issued by United States government-sponsored enterprises
|
151,034 | 4,625 | (60 | ) | 155,599 | |||||||||||
Money market funds
|
283,564 | - | - | 283,564 | ||||||||||||
Debt securities issued by United States Treasury
|
565,930 | 2,534 | (8 | ) | 568,456 | |||||||||||
Total
|
$ | 2,541,872 | $ | 11,818 | $ | (236 | ) | $ | 2,553,454 | |||||||
Classified as:
|
||||||||||||||||
Cash equivalents
|
$ | 510,546 | ||||||||||||||
Marketable securities
|
2,042,908 | |||||||||||||||
Total
|
$ | 2,553,454 |
January 30, 2011
|
||||||||||||||||
Amortized
Cost
|
Unrealized
Gain
|
Unrealized
Loss
|
Estimated
Fair Value
|
|||||||||||||
(In thousands)
|
||||||||||||||||
Debt securities of United States government agencies
|
$ | 531,789 | $ | 1,034 | $ | (226 | ) | $ | 532,597 | |||||||
Corporate debt securities
|
925,226 | 3,354 | (208 | ) | 928,372 | |||||||||||
Mortgage backed securities issued by United States government-sponsored enterprises
|
140,844 | 4,599 | (21 | ) | 145,422 | |||||||||||
Money market funds
|
132,586 | - | - | 132,586 | ||||||||||||
Debt securities issued by United States Treasury
|
435,091 | 1,939 | (18 | ) | 437,012 | |||||||||||
Total
|
$ | 2,165,536 | $ | 10,926 | $ | (473 | ) | $ | 2,175,989 | |||||||
Classified as:
|
||||||||||||||||
Cash equivalents
|
$ | 350,787 | ||||||||||||||
Marketable securities
|
1,825,202 | |||||||||||||||
Total
|
$ | 2,175,989 |
May 1, 2011
|
January 30, 2011
|
|||||||||||||||
Amortized
Cost
|
Estimated
Fair Value
|
Amortized
Cost
|
Estimated
Fair Value
|
|||||||||||||
Less than one year
|
$ | 1,504,472 | $ | 1,507,268 | $ | 1,176,046 | $ | 1,178,733 | ||||||||
Due in 1 - 5 years
|
955,123 | 961,438 | 899,993 | 904,926 | ||||||||||||
Mortgage-backed securities issued by government-sponsored enterprises not due at a single maturity date
|
82,277 | 84,748 | 89,497 | 92,330 | ||||||||||||
Total
|
$ | 2,541,872 | $ | 2,553,454 | $ | 2,165,536 | $ | 2,175,989 |
Fair value measurement at reporting date using
|
||||||||||||
Quoted Prices
in Active Markets for Identical Assets
|
Significant Other Observable Inputs
|
|||||||||||
May 1, 2011
|
(Level 1)
|
(Level 2)
|
||||||||||
(In thousands)
|
||||||||||||
Debt securities issued by United States government agencies (1)
|
$ | 587,384 | $ | - | $ | 587,384 | ||||||
Debt securities issued by United States Treasury (2)
|
568,456 | - | 568,456 | |||||||||
Corporate debt securities (3)
|
958,451 | - | 958,451 | |||||||||
Mortgage-backed securities issued by government-sponsored entities (4)
|
155,599 | - | 155,599 | |||||||||
Money market funds (5)
|
283,564 | 283,564 | - | |||||||||
Total cash equivalents and marketable securities
|
$ | 2,553,454 | $ | 283,564 | $ | 2,269,890 |
(1)
|
Includes $67.3 million in Cash Equivalents and $520.1 million in Marketable Securities on the Condensed Consolidated Balance Sheet.
|
(2)
|
Includes $103.4 million in Cash Equivalents and $465.1 million in Marketable Securities on the Condensed Consolidated Balance Sheet.
|
(3)
|
Includes $56.4 million in Cash Equivalents and $902.1 million in Marketable Securities on the Condensed Consolidated Balance Sheet.
|
(4)
|
Included in Marketable Securities on the Condensed Consolidated Balance Sheet.
|
(5)
|
Included in Cash Equivalents on the Condensed Consolidated Balance Sheet.
|
|
Fair Market Value
|
Straight-Line Amortization Period
|
|||
(In thousands)
|
(Years)
|
||||
Property and equipment
|
$
|
2,433
|
1-2
|
||
Trademarks
|
11,310
|
5
|
|||
Goodwill
|
85,418
|
-
|
|||
Total
|
$
|
99,161
|
May 1, 2011
|
January 30, 2011
|
|||||||||||||||||||||||
Gross
Carrying
Amount
|
Accumulated
Amortization
|
Net Carrying
Amount
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
Net Carrying
Amount
|
|||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
Technology licenses
|
$ | 321,350 | $ | (69,646 | ) | $ | 251,704 | $ | 320,477 | $ | (62,791 | ) | $ | 257,686 | ||||||||||
Acquired intellectual property
|
76,264 | (63,951 | ) | 12,313 | 76,264 | (61,175 | ) | 15,089 | ||||||||||||||||
Patents
|
31,278 | (16,534 | ) | 14,744 | 31,278 | (15,308 | ) | 15,970 | ||||||||||||||||
Total intangible assets
|
$ | 428,892 | $ | (150,131 | ) | $ | 278,761 | $ | 428,019 | $ | (139,274 | ) | $ | 288,745 |
May 1,
2011
|
January 30,
2011
|
|||||||
Inventories:
|
(In thousands)
|
|||||||
Raw materials
|
$
|
125,346
|
$
|
67,880
|
||||
Work in-process
|
44,900
|
72,698
|
||||||
Finished goods
|
210,718
|
204,947
|
||||||
Total inventories
|
$
|
380,964
|
$
|
345,525
|
|
May 1,
2011
|
January 30,
2011
|
||||||
Prepaid Expenses and Other:
|
(In thousands)
|
|||||||
Prepaid maintenance
|
$
|
13,942
|
$
|
12,165
|
||||
Prepaid insurance
|
4,756
|
3,512
|
||||||
Prepaid taxes
|
2,287
|
1,364
|
||||||
Prepaid rent
|
3,392
|
3,599
|
||||||
Other
|
12,223
|
11,996
|
||||||
Total prepaid expenses and other
|
$
|
36,600
|
$
|
32,636
|
||||
May 1,
2011
|
January 30,
2011
|
|||||||
(In thousands)
|
||||||||
Accrued Liabilities:
|
||||||||
Deferred revenue
|
$
|
281,790
|
$
|
245,596
|
||||
Accrued customer programs (1)
|
165,018
|
171,163
|
||||||
Warranty accrual (2)
|
80,725
|
107,897
|
||||||
Accrued payroll and related expenses
|
44,112
|
71,915
|
||||||
Accrued legal settlement (3)
|
30,600
|
30,600
|
||||||
Deferred rent
|
629
|
3,268
|
||||||
Taxes payable, short- term
|
5,916
|
4,576
|
||||||
Other
|
26,081
|
21,529
|
||||||
Total accrued liabilities and other
|
$
|
634,871
|
$
|
656,544
|
May 1,
2011
|
January 30,
2011
|
|||||||
(In thousands)
|
||||||||
Other Long-Term Liabilities:
|
||||||||
Deferred income tax liability
|
$
|
54,544
|
$
|
46,129
|
||||
Income taxes payable, long term
|
56,460
|
57,590
|
||||||
Asset retirement obligation
|
9,501
|
9,694
|
||||||
Deferred revenue
|
98,583
|
163,000
|
||||||
Other long-term liabilities
|
65,725
|
71,300
|
||||||
Total other long-term liabilities
|
$
|
284,813
|
$
|
347,713
|
Three Months Ended
|
||||||||||
May 1,
2011
|
May 2,
2010
|
|||||||||
(In thousands) | ||||||||||
Balance at beginning of period (1)
|
$ | 107,896 | $ | 92,655 | ||||||
Additions
|
1,406 | 1,170 | ||||||||
Deductions (2)
|
(28,578 | ) | (46,262 | ) | ||||||
Balance at end of period
|
$ | 80,724 | $ | 47,563 |
Three Months Ended
|
|||||||
May 1,
2011
|
May 2,
2010
|
||||||
(In thousands)
|
|||||||
Net income
|
$
|
135,219
|
$
|
137,594
|
|||
Net change in unrealized gains (losses) on available-for-sale securities, net of tax
|
903
|
(1,084
|
)
|
||||
Reclassification adjustments for net realized losses on available-for-sale securities included in net loss, net of tax
|
(54
|
)
|
(214
|
)
|
|||
Total comprehensive income
|
$
|
136,068
|
$
|
136,296
|
GPU
|
PSB
|
CPB
|
All Other
|
Consolidated
|
||||||||||||||||
(In thousands)
|
||||||||||||||||||||
Three Months Ended May 1, 2011:
|
||||||||||||||||||||
Revenue
|
$
|
637,589
|
$
|
201,841
|
$
|
122,609
|
$
|
-
|
$
|
962,039
|
||||||||||
Depreciation and amortization expense
|
$
|
29,028
|
$
|
6,118
|
$
|
12,618
|
$
|
-
|
$
|
47,764
|
||||||||||
Operating income (loss)
|
$
|
120,283
|
$
|
69,885
|
$
|
(35,306
|
)
|
$
|
-
|
$
|
154,862
|
|||||||||
Three Months Ended May 2, 2010:
|
||||||||||||||||||||
Revenue
|
$
|
780,853
|
$
|
189,730
|
$
|
31,230
|
$
|
-
|
$
|
1,001,813
|
||||||||||
Depreciation and amortization expense
|
$
|
34,859
|
$
|
5,395
|
$
|
6,893
|
$
|
-
|
$
|
47,147
|
||||||||||
Operating income (loss)
|
$
|
115,344
|
$
|
73,865
|
$
|
(41,816
|
)
|
$
|
-
|
$
|
147,393
|
Three Months Ended
|
||||||||
May 1,
2011
|
May 2,
2010
|
|||||||
(In thousands)
|
||||||||
Revenue:
|
||||||||
China
|
$
|
289,484
|
$
|
377,319
|
||||
Taiwan
|
282,937
|
278,125
|
||||||
Other Asia Pacific
|
132,587
|
127,635
|
||||||
United States
|
109,318
|
87,016
|
||||||
Other Americas
|
75,130
|
64,901
|
||||||
Europe
|
72,583
|
66,817
|
||||||
Total revenue
|
$
|
962,039
|
$
|
1,001,813
|
Three Months Ended
|
||||||||
May 1,
2011
|
May 2,
2010
|
|||||||
Revenue
|
100.0
|
%
|
100.0
|
%
|
||||
Cost of revenue
|
49.6
|
54.4
|
||||||
Gross profit
|
50.4
|
45.6
|
||||||
Operating expenses
|
||||||||
Research and development
|
24.1
|
21.8
|
||||||
Sales, general and administrative
|
10.2
|
9.1
|
||||||
Total operating expenses
|
34.3
|
30.9
|
||||||
Income from operations
|
16.1
|
14.7
|
||||||
Interest and other income, net
|
0.2
|
0.3
|
||||||
Income before income tax expense
|
16.3
|
15.0
|
||||||
Income tax expense
|
2.2
|
1.3
|
||||||
Net income
|
14.1
|
%
|
13.7
|
%
|
Three Months Ended
|
||||||||||||||||
May 1,
2011
|
May 2,
2010
|
$
Change
|
%
Change
|
|||||||||||||
(In millions)
|
||||||||||||||||
Research and development expenses
|
$ | 231.5 | $ | 218.1 | $ | 13.4 | 6.1 | % | ||||||||
Sales, general and administrative expenses
|
98.1 | 90.9 | 7.2 | 7.9 | % | |||||||||||
Total operating expenses
|
$ | 329.6 | $ | 309.0 | $ | 20.6 | 6.7 | % | ||||||||
Research and development as a percentage of net revenue
|
24.1 | % | 21.8 | % | ||||||||||||
Sales, general and administrative as a percentage of net revenue
|
10.2 | % | 9.1 | % |
As of
May 1,
2011
|
As of
January 30,
2011
|
|||||||
(In millions)
|
||||||||
Cash and cash equivalents
|
$
|
683.6
|
$
|
665.4
|
||||
Marketable securities
|
2,042.9
|
1,825.2
|
||||||
Cash, cash equivalents, and marketable securities
|
$
|
2,726.5
|
$
|
2,490.6
|
Three Months Ended
|
||||||||
May 1,
|
May 2,
|
|||||||
2011
|
2010
|
|||||||
(In millions)
|
||||||||
Net cash provided by (used in) operating activities
|
$
|
172.2
|
$
|
(5.4
|
)
|
|||
Net cash used in investing activities
|
$
|
(252.5
|
)
|
$
|
(57.3
|
)
|
||
Net cash provided by financing activities
|
$
|
98.6
|
$
|
62.8
|
•
|
Effectively identify and capitalize upon opportunities in new markets;
|
•
|
Timely complete and introduce new products and technologies;
|
•
|
Transition our semiconductor products to increasingly smaller line width geometries; and
|
•
|
Obtain sufficient foundry capacity and packaging materials.
|
•
|
anticipate the features and functionality that customers and consumers will demand;
|
•
|
incorporate those features and functionalities into products that meet the exacting design requirements of our customers;
|
•
|
price our products competitively; and
|
•
|
introduce products to the market within our customers’ limited design cycles
|
•
|
suppliers of GPUs, including chipsets, that incorporate 3D graphics functionality as part of their existing solutions, such as Advanced Micro Devices Inc., or AMD, Intel Corporation, or Intel, Matrox Electronics Systems Ltd., Silicon Integrated Systems, or SIS, and VIA Technologies, Inc.; and
|
●
|
suppliers of system-on-a-chip products that support tablets, netbooks, PNDs, PMPs, PDAs, cellular phones, handheld devices or embedded devices such as AMD, Broadcom Corporation, Freescale Semiconductor, Inc., Fujitsu Limited, Imagination Technologies Ltd., Intel, Marvell Technology Group Ltd., NEC Corporation, Qualcomm Incorporated, Renesas Technology Corp., Samsung Electronics Co., Ltd., Seiko Epson Corporation, STMicroelectronics, Texas Instruments Incorporated, and Toshiba America Electronic Components, Inc.
|
•
|
continue to keep pace with technological developments;
|
•
|
develop and introduce new products, services, technologies and enhancements on a timely basis;
|
•
|
become a preferred partner for operating system platforms, such as Android and Windows Mobile;
|
•
|
transition our semiconductor products to increasingly smaller line width geometries;
|
•
|
obtain sufficient foundry capacity and packaging materials; and
|
•
|
succeed in significant foreign markets, such as China and India.
|
•
|
substantially all of our sales are made on a purchase order basis, which permits our customers to cancel, change or delay product purchase commitments with little or no notice to us and without penalty;
|
•
|
our customers may develop their own solutions;
|
•
|
our customers may purchase products from our competitors; or
|
•
|
our customers may discontinue sales or lose market share in the markets for which they purchase our products.
|
•
|
changes in business and economic conditions, including downturns in the semiconductor industry and/or overall economy;
|
•
|
changes in consumer confidence caused by changes in market conditions, including changes in the credit market, expectations for inflation, and energy prices;
|
•
|
if there were a sudden and significant decrease in demand for our products;
|
•
|
if there were a higher incidence of inventory obsolescence because of rapidly changing technology and customer requirements;
|
•
|
if we fail to estimate customer demand properly for our older products as our newer products are introduced; or
|
•
|
if our competition were to take unexpected competitive pricing actions.
|
•
|
the mix of our products sold;
|
•
|
average selling prices;
|
•
|
introduction of new products;
|
•
|
product transitions;
|
•
|
sales discounts;
|
•
|
unexpected pricing actions by our competitors;
|
•
|
the cost of product components; and
|
•
|
the yield of wafers produced by the foundries that manufacture our products.
|
•
|
international economic and political conditions, such as political tensions between countries in which we do business;
|
•
|
unexpected changes in, or impositions of, legislative or regulatory requirements;
|
•
|
complying with a variety of foreign laws;
|
•
|
differing legal standards with respect to protection of intellectual property and employment practices;
|
•
|
cultural differences in the conduct of business;
|
•
|
inadequate local infrastructure that could result in business disruptions;
|
•
|
exporting or importing issues related to export or import restrictions, tariffs, quotas and other trade barriers and restrictions;
|
•
|
financial risks such as longer payment cycles, difficulty in collecting accounts receivable and fluctuations in currency exchange rates;
|
•
|
imposition of additional taxes and penalties; and
|
•
|
other factors beyond our control such as terrorism, civil unrest, war and diseases such as severe acute respiratory syndrome and the Avian flu.
|
•
|
difficulty in combining the technology, products, operations or workforce of the acquired business with our business;
|
•
|
difficulty in operating in a new or multiple new locations;
|
•
|
disruption of our ongoing businesses or the ongoing business of the company we invest in or acquire;
|
•
|
difficulty in realizing the potential financial or strategic benefits of the transaction;
|
•
|
difficulty in maintaining uniform standards, controls, procedures and policies;
|
•
|
difficulty integrating the target’s accounting, management information, human resources and other administrative systems;
|
•
|
disruption of or delays in ongoing research and development efforts;
|
•
|
diversion of capital and other resources;
|
•
|
assumption of liabilities;
|
•
|
incurring acquisition-related costs or amortization costs for acquired intangible assets that could impact our operating results;
|
•
|
diversion of resources and unanticipated expenses resulting from litigation arising from potential or actual business acquisitions or investments;
|
•
|
potential failure of the due diligence processes to identify significant issues with product quality, architecture and development, or legal and financial contingencies, among other things;
|
•
|
difficulties in entering into new markets in which we have limited or no experience and where competitors in such markets have stronger positions; and
|
•
|
incurring significant exit charges if products acquired in business combinations are unsuccessful;
|
•
|
potential inability to obtain, or obtain in a timely manner, approvals from governmental authorities, which could delay or prevent such acquisitions or investments;
|
•
|
potential delay in customer and distributor purchasing decisions due to uncertainty about the direction of our product offerings; and
|
•
|
impairment of relationships with employees
,
vendors and customers, or the loss of any of our key employees
, vendors
or customers our target’s key employees
, vendors
or customers, as a result of our acquisition or investment.
|
●
|
the jurisdictions in which profits are determined to be earned and taxed;
|
●
|
adjustments to estimated taxes upon finalization of various tax returns;
|
●
|
changes in available tax credits;
|
●
|
changes in share-based compensation expense;
|
●
|
changes in tax laws, the interpretation of tax laws either in the United States or abroad or the issuance of new interpretative accounting guidance related to uncertain transactions and calculations where the tax treatment was previously uncertain; and
|
●
|
the resolution of issues arising from tax audits with various tax authorities.
|
•
|
the commercial significance of our operations and our competitors’ operations in particular countries and regions;
|
•
|
the location in which our products are manufactured;
|
•
|
our strategic technology or product directions in different countries; and
|
•
|
the degree to which intellectual property laws exist and are meaningfully enforced in different jurisdictions.
|
•
|
the possibility of environmental contamination and the costs associated with mitigating any environmental problems;
|
•
|
adverse changes in the value of these properties, due to interest rate changes, changes in the market in which the property is located, or other factors;
|
•
|
the risk of loss if we decide to sell and are not able to recover all capitalized costs;
|
•
|
increased cash commitments for the possible construction of a campus;
|
•
|
the possible need for structural improvements in order to comply with zoning, seismic and other legal or regulatory requirements;
|
•
|
increased operating expenses for the buildings or the property or both;
|
•
|
possible disputes with third parties, such as neighboring owners or others, related to the buildings or the property or both; and
|
•
|
the risk of financial loss in excess of amounts covered by insurance, or uninsured risks, such as the loss caused by damage to the buildings as a result of earthquakes, floods and or other natural disasters.
|
•
|
the ability of our Board to create and issue preferred stock without prior stockholder approval;
|
•
|
the prohibition of stockholder action by written consent;
|
•
|
a classified Board; and
|
•
|
advance notice requirements for director nominations and stockholder proposals.
|
Incorporated by Reference
|
|||||||||||||||
Exhibit No.
|
Exhibit Description
|
Schedule/Form
|
File Number
|
Exhibit
|
Filing Date
|
||||||||||
3.1
|
Certificate of Amendment of Amended and Restated Certificate of Incorporation of NVIDIA Corporation
|
8-K
|
0-23985
|
3.1
|
05/24/2011
|
||||||||||
3.2
|
Amended and Restated Bylaws of NVIDIA Corporation
|
8-K
|
0-23985
|
3.2
|
05/24/2011
|
||||||||||
10.38
|
Transition and Consulting Agreement, dated March 15, 2011, between David L.White and NVIDIA Corporation
|
8-K
|
0-23985
|
10.1
|
03/15/2011
|
||||||||||
10.39+
|
Fiscal Year 2012 Variable Compensation Plan
|
8-K
|
0-23985
|
10.1
|
03/25/2011
|
||||||||||
10.40+
|
Offer Letter, dated March 16, 2011, between NVIDIA Corporation and Michael Byron
|
8-K
|
0-23985
|
10.2
|
03/25/2011
|
||||||||||
10.41+*
|
2007 Equity Incentive Plan - Non Statutory Stock Option (Annual Grant - Board Service)
|
||||||||||||||
31.1*
|
Certification of Chief Executive Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934
|
||||||||||||||
31.2*
|
Certification of Chief Financial Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934
|
||||||||||||||
32.1#*
|
Certification of Chief Executive Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934
|
||||||||||||||
32.2#*
|
Certification of Chief Financial Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934
|
||||||||||||||
101.INS*
|
XBRL Instance Document
|
||||||||||||||
101.SCH*
±
|
XBRL Taxonomy Extension Schema Document
|
||||||||||||||
101.CAL*
±
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
||||||||||||||
101.LAB*
±
|
XBRL Taxonomy Extension Labels Linkbase Document
|
||||||||||||||
101.PRE*
±
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
||||||||||||||
|
|||||||||||||||
101.DEF*
±
|
XBRL Taxonomy Extension Definition Linkbase Document
|
Date: May 27, 2011
|
|||
NVIDIA Corporation
|
|||
By:
|
/s/
Karen Burns
|
||
Karen Burns
|
|||
Interim Chief Financial Officer (Duly Authorized Officer and Principal Financial Officer)
|
|||
Incorporated by Reference
|
|||||||||||||||
Exhibit No.
|
Exhibit Description
|
Schedule/Form
|
File Number
|
Exhibit
|
Filing Date
|
||||||||||
3.1
|
Certificate of Amendment of Amended and Restated Certificate of Incorporation of NVIDIA Corporation
|
8-K
|
0-23985
|
3.1
|
05/24/2011
|
||||||||||
3.2
|
Amended and Restated Bylaws of NVIDIA Corporation
|
8-K
|
0-23985
|
3.2
|
05/24/2011
|
||||||||||
10.38
|
Transition and Consulting Agreement, dated March 15, 2011, between David L.White and NVIDIA Corporation
|
8-K
|
0-23985
|
10.1
|
03/15/2011
|
||||||||||
10.39+
|
Fiscal Year 2012 Variable Compensation Plan
|
8-K
|
0-23985
|
10.1
|
03/25/2011
|
||||||||||
10.40+
|
Offer Letter, dated March 16, 2011, between NVIDIA Corporation and Michael Byron
|
8-K
|
0-23985
|
10.2
|
03/25/2011
|
||||||||||
10.41+*
|
2007 Equity Incentive Plan - Non Statutory Stock Option (Annual Grant - Board Service)
|
||||||||||||||
31.1*
|
Certification of Chief Executive Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934
|
||||||||||||||
31.2*
|
Certification of Chief Financial Officer as required by Rule 13a-14(a) of the Securities Exchange Act of 1934
|
||||||||||||||
32.1#*
|
Certification of Chief Executive Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934
|
||||||||||||||
32.2#*
|
Certification of Chief Financial Officer as required by Rule 13a-14(b) of the Securities Exchange Act of 1934
|
||||||||||||||
101.INS*
|
XBRL Instance Document
|
||||||||||||||
101.SCH*
±
|
XBRL Taxonomy Extension Schema Document
|
||||||||||||||
101.CAL*
±
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
||||||||||||||
101.LAB*
±
|
XBRL Taxonomy Extension Labels Linkbase Document
|
||||||||||||||
101.PRE*
±
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
||||||||||||||
|
|||||||||||||||
101.DEF*
±
|
XBRL Taxonomy Extension Definition Linkbase Document
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|